Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Theranos in Court: Jury Finds Balwani Guilty on All 12 Counts
Federal San Jose jury finds ex-Theranos COO guilty of all 10 ten counts of wire fraud and two counts of conspiracy to commit wire fraud.
The 6 Changes Labs Need to Know About the 2023 Physicians Fee Schedule
Here are the aspects of the proposed rule most likely to have an impact on labs and the businesses that own them.
Congress Acts to End PAMA Price Cutting Reign of Terror
After years of resistance, the lab industry’s hopes and prayers for relief from the flawed pricing scheme may soon be answered.
6 Key Items in CMS’ Proposed 2023 Physicians Fee Schedule
Changes to PAMA reporting timelines and requirements, as well as payment cuts, are just some of the main takeaways labs should know about.
15 Doctors Pay $2.8 Million to Settle Lab Referral Kickback Allegations
A total of 33 doctors have now paid settlements in relation to an alleged lab testing referrals scheme, according to the DOJ.
Recent Studies Show Promise of AI and Wearables for COVID-19 Screening
Research shows that AI algorithms trained with data collected from wearable devices were effective in identifying COVID-19.
Liquid Biopsy Can Rule Out Need for Chemotherapy After Stage II Colon Cancer Surgery
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
Theranos In Court: Balwani Convicted on All Counts
The former Theranos CEO was found guilty of 10 ten counts of wire fraud and two counts of conspiracy to commit wire fraud.
As Concern Over Monkeypox Grows, Testing Expands in US
Labcorp begins offering CDC’s PCR test for orthopoxviruses, including monkeypox, with plans to further expand testing capacity.
Blood-Based Tests Can Detect Early-Stage Lung Cancer
Team creates a mass spectrometry-based blood lipid test that, when combined with AI, identifies early signs of the disease.